Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

ViroPharma's new antiinfluenza agents

April 17, 1998

Selective MMP-13 inhibitors in the pipeline at Monsanto

April 17, 1998

New growth factor inhibitors with antiproliferative and antipermeability effects

April 17, 1998

New anti-HSV agents synthesized in Taiwan

April 16, 1998

Genentech claims TF-FVIIa hybrids for coagulation disorders

April 16, 1998

New approach to TB vaccination described by Merck

April 16, 1998

Sanofi discloses phenoxypropanolamines as beta3-adrenoceptor antagonists

April 16, 1998

Antitumor illudin analogues discovered at U. of California

April 16, 1998

Kynurenine 3-monooxygenase inhibitors under study at P&U as neuroprotectants

April 16, 1998

CRF antagonists for stress-related disorders from DuPont Merck

April 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...